Subiaco-based PharmAust Ltd, through its wholly owned subsidiary Epichem Pty Ltd, has entered into a joint venture agreement with Curtin University to develop oral insulin for the treatment of diabetes.

Subiaco-based PharmAust Ltd, through its wholly owned subsidiary Epichem Pty Ltd, has entered into a joint venture agreement with Curtin University to develop oral insulin for the treatment of diabetes.